What Veincentre does

VeinCentre is a UK-based private healthcare provider founded in 2003 by Dr David West in Stoke-on-Trent, operating the country's largest network of specialist vein treatment clinics with over 40 purpose-built locations across England, Scotland, and Wales. The company focuses exclusively on minimally invasive treatments for varicose veins, thread veins (spider veins), and venous leg ulcers, performing more than 50,000 procedures to date and reporting a 99% success rate for its primary intervention, Endovenous Laser Ablation (EVLA).

The core clinical offering centres on EVLA as the primary varicose vein treatment, performed under duplex ultrasound guidance without general anaesthetic in approximately one hour. This is complemented by foam sclerotherapy, avulsions/phlebectomies, microsclerotherapy for leg thread veins, and thermocoagulation for facial thread veins. Care is consultant-led, with the same vascular specialist managing the patient from initial duplex ultrasound consultation through treatment and follow-up. Dr Mark Bratby, a Consultant Interventional Radiologist with prior Oxford University Hospital credentials, was appointed Medical Director in November 2021 and oversees 49 consultants with practising privileges across the network.

VeinCentre operates a direct-to-consumer model with no GP referral required. Revenue is generated primarily through self-pay patients at fixed upfront prices (£250 consultation, £450-£3,600 per treatment), supplemented by acceptance of all major UK private health insurers (BUPA, AXA, Cigna, WPA, Vitality Health, Aviva, Aetna, Healix, Allianz) and monthly finance plans through a Chrysalis Finance partnership. Marketing relies on ITV This Morning media appearances, celebrity patient endorsements, and over 1,900 verified Trustpilot reviews. The company is privately held as Veincentre Ltd (England and Wales), with no disclosed external private equity or venture capital investment.

Name

Veincentre

Legal name

Veincentre Ltd

Website

https://veincentre.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

VeinCentre is the UK's largest specialist vein treatment network, operating 40+ purpose-built clinics offering minimally invasive treatments (EVLA, sclerotherapy, thermocoagulation) for varicose veins, thread veins, and venous leg ulcers. It serves self-pay and insured patients through a consultant-led, direct-to-consumer model.

Ownership category

akta.pro rank

Headquarters

HQ city

Stoke-on-trent

HQ country

United Kingdom

HQ region

Europe

Offices44 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Self-Pay Private Treatment: Majority of patients self-fund treatment. Fixed upfront pricing with no hidden costs. Consultation fee of £250, with treatment prices ranging from £450 to £3,600 depending on procedure type and whether unilateral or bilateral.
2. Private Health Insurance: Accepts all major private health insurers including BUPA, AXA, Cigna, WPA, Vitality Health, Aviva, Aetna, Healix, and Allianz. Patients may require pre-authorisation from insurer.
3. Finance Plans: Partnership with Chrysalis Finance provides monthly payment options. Minimum deposit of £100 required. Credit application processed online.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Veincentre provides consultant-led, minimally invasive treatments for varicose veins, thread veins (legs and face), and venous leg ulcers across 40+ purpose-built specialist clinics in the UK. The core service offering includes consultation with duplex ultrasound scanning, EVLA (Endovenous Laser Ablation) as the primary varicose vein treatment, foam sclerotherapy, avulsions/phlebectomies, microsclerotherapy for leg thread veins, and thermocoagulation for facial thread veins. All procedures are walk-in, walk-out with no general anaesthetic required.

Product overview

VeinCentre is the UK's largest network of specialist clinics dedicated to treating varicose veins, thread veins, and venous leg ulcers. The company operates a unified service model offering consultant-led, minimally invasive treatments through 40+ purpose-built clinics nationwide. The core treatment pathway consists of consultation with duplex ultrasound imaging, followed by EVLA (Endovenous Laser Ablation) as the primary intervention for varicose veins, combined with foam sclerotherapy and/or phlebectomies for visible veins. Thread veins on legs are treated with microsclerotherapy, while facial thread veins use thermocoagulation. All patients receive the same consultant throughout their journey from initial consultation through treatment and follow-up. The company also offers venous leg ulcer treatment and flexible finance options through Chrysalis Finance.

Differentiator

Problem solved

Functional benefit

Products and services

• Varicose Veins Treatment Comprehensive treatment for varicose veins using minimally invasive procedures including EVLA (Endovenous Laser Ablation), foam sclerotherapy, and avulsions/phlebectomies. Walk-in, walk-out procedure taking approximately one hour with no general anaesthetic required. For adult patients with visible or symptomatic varicose veins.
• EVLA (Endovenous Laser Ablation) Primary treatment for varicose veins using laser technology to address the underlying cause of venous reflux. NICE-recommended procedure with 99% success rate. Walk-in, walk-out procedure under local anaesthetic.
• Foam Sclerotherapy Injection-based treatment using foam sclerosant to close off visible varicose veins and thread veins. Typically used as secondary treatment following EVLA.
• Avulsions / Phlebectomies Minimally invasive surgical removal of varicose veins through tiny incisions (needle punctures to 3mm cuts) to extract visible veins.
• Thread Veins Treatment (Leg) Treatment for leg thread veins (spider veins) using microsclerotherapy injections to collapse and fade visible veins. Cosmetic-focused treatment for adult patients.
• Microsclerotherapy Injection treatment specifically for thread/spider veins on the legs using a liquid sclerosant solution.
• Facial Thread Veins Treatment Treatment for facial thread veins using thermocoagulation technology to target and eliminate visible veins on the face.
• Thermocoagulation Heat-based treatment for facial thread veins that uses electrical current to coagulate and eliminate small visible veins.
• Venous Leg Ulcers Treatment Specialized treatment for venous leg ulcers including consultation, ABPI testing, duplex ultrasound scan, and appropriate interventions to promote healing. For patients with venous leg ulcers caused by underlying vein disease.
• Consultation & Duplex Ultrasound Scan Initial consultation including comprehensive duplex ultrasound imaging to assess venous insufficiency and develop a personalized treatment plan. Same consultant manages care from consultation through treatment and follow-up. Priced at £250 (£350 for ulcer consultation with ABPI test).

Quantifiable outcome

• 99% success rate for EVLA treatment
• +3 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators9 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• Spire Healthcare: Listed UK private hospital group offering vascular surgery including vein treatments within broader elective-care portfolio. Comparable on private-pay elective vascular pathway and consultant-led model; much broader and hospital-based.
• Transform Hospital Group: Large UK private cosmetic surgery and medical-aesthetics provider offering vein treatments among a broader portfolio. Comparable on self-pay elective healthcare delivery and clinic-network model, though not vein-specialist.
• BMI Healthcare (Circle Health Group): One of the largest UK private hospital operators offering vascular and venous treatments alongside a wide elective-care portfolio. Comparable on private consultant model and UK footprint; broader and not vein-specialist.
• sk:n Clinics: UK national chain of doctor-led skin and aesthetics clinics with significant clinic footprint and self-pay consumer model. Comparable on multi-site, DTC elective healthcare delivery; veins are a peripheral service line for sk:n.

Direct peers

• The Private Clinic Group: UK private medical group offering minimally invasive varicose vein treatments (EVLA, sclerotherapy, VenaSeal) alongside other cosmetic procedures. Directly comparable to VeinCentre on service mix, customer base and self-pay pricing model.
• River Aesthetics (Court House Clinics heritage): UK doctor-led aesthetics clinic group offering thread vein and sclerotherapy treatments. Comparable on DTC vein/aesthetic delivery, though smaller scale and more regionally focused than VeinCentre.
• The Harley Medical Group: UK cosmetic surgery and aesthetic treatment provider with a national clinic network and self-pay model. Comparable on DTC elective healthcare delivery and multi-site footprint, with overlapping aesthetic/medical positioning.
• Veincentre (Ireland/competitor brands) — e.g. UK Vein & Vascular Clinics: Smaller UK-based specialist vein clinics offering EVLA and sclerotherapy in dedicated outpatient settings, overlapping with VeinCentre on procedure types, patient profile and direct-to-consumer delivery.

Regional players

• Vein Clinics of America (now USA Vein Clinics): US-focused specialist vein clinic network with EVLA and sclerotherapy offerings. Comparable on specialist vein-clinic model and procedure mix; geographic footprint is the US, not the UK.

Others

• Doccla / Doctify: UK digital health platforms enabling discovery and booking of private specialists. Not a direct competitor but adjacent ecosystem: a key patient-acquisition and reputation channel for self-pay elective providers like VeinCentre.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• Xx.com/veincentreltd
• Facebookfacebook.com/veincentreltd
• LinkedInlinkedin.com/company/veincentre

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veincentre